MONITILLO, LUIGIA
 Distribuzione geografica
Continente #
NA - Nord America 1.393
EU - Europa 811
AS - Asia 289
AF - Africa 15
SA - Sud America 4
OC - Oceania 2
Totale 2.514
Nazione #
US - Stati Uniti d'America 1.378
CN - Cina 224
IT - Italia 127
AT - Austria 110
IE - Irlanda 102
SE - Svezia 99
FR - Francia 81
FI - Finlandia 61
DK - Danimarca 52
DE - Germania 41
UA - Ucraina 39
BE - Belgio 34
KR - Corea 30
PL - Polonia 22
GB - Regno Unito 19
SN - Senegal 15
VN - Vietnam 14
CA - Canada 13
GR - Grecia 12
IN - India 6
SA - Arabia Saudita 6
RU - Federazione Russa 4
UZ - Uzbekistan 4
BR - Brasile 3
ES - Italia 3
AU - Australia 2
NL - Olanda 2
PR - Porto Rico 2
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
MD - Moldavia 1
SG - Singapore 1
TR - Turchia 1
Totale 2.514
Città #
Chandler 223
Beijing 167
Ann Arbor 115
Vienna 110
Dublin 101
Ashburn 71
Dearborn 67
Fairfield 64
Villeurbanne 64
Wilmington 61
Houston 57
Woodbridge 53
Nyköping 45
Torino 45
Medford 38
Brussels 34
Princeton 30
Jacksonville 29
San Mateo 28
Warsaw 22
Cambridge 20
Pisa 20
Fremont 19
Guangzhou 17
Seattle 16
Milan 15
Dong Ket 10
Toronto 9
Turin 9
Washington 9
Boardman 7
Hefei 7
Nanjing 7
Boston 6
Norwalk 6
Wayne 6
Düsseldorf 5
Mcallen 4
Munich 4
Philadelphia 4
San Jose 4
Auburn Hills 3
Chengdu 3
Florence 3
Helsinki 3
Phoenix 3
Redwood City 3
San Diego 3
Coimbatore 2
Flushing 2
Mountain View 2
Nanchang 2
Naples 2
Ottawa 2
Recife 2
Saint Petersburg 2
San Francisco 2
Shaoxing 2
Taranto 2
Zhengzhou 2
Ardabil 1
Arlington 1
Baltimore 1
Baotou 1
Bari 1
Berlin 1
Bilbao 1
Borgaro Torinese 1
Borgo San Dalmazzo 1
Brno 1
Changsha 1
Chaoyang 1
Chicago 1
Chisinau 1
Dallas 1
Delhi 1
Des Moines 1
Duncan 1
Falls Church 1
Fort Belvoir 1
Grevenbroich 1
Groningen 1
Hangzhou 1
Hebei 1
Jinan 1
Kunming 1
Köln 1
Madrid 1
Massapequa Park 1
New York 1
Ningbo 1
Noto 1
Odesa 1
Omegna 1
Padova 1
Pavia 1
Portland 1
Ramat Gan 1
Redmond 1
San Juan 1
Totale 1.713
Nome #
HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing data 373
Prospective molecular monitoring of minimal residual disease after nonmyeloablative allografting in newly diagnosed multiple myeloma 192
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment. 120
High Rates of Prolonged Molecular Remissions After Tandem Autologous-Nonmyeloablative Allografting in Newly Diagnosed Myeloma 119
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 107
TELOMERES SHORTEN DURING CHRONIC LYMPHOCYTIC LEUKEMIA(CLL) EVOLUTION: AN ANALYSIS ON 88 CASES 106
Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations 100
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR 97
Telomere length is an independent predictor of survival, treatment requirement and Richter’s syndrome transformation in chronic lymphocytic leukemia 89
Telomere lenght measurement in the clinically oriented research setting: a comparison between Southern blot (SB), real time quantitative PCR (RQ-PCR) and FLOW-FISH (FF) 83
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: Evidences from long term follow-up 81
Expression of telomeric proteins in chronic lymphocytic leukemia (CLL) 81
High Rates of Prolonged Molecular Remissions After Tandem Autologous-Nonmyeloablative Allografting in Newly Diagnosed Myeloma 79
Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial 75
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance. 73
LONG-TERM RESULTS of the GIMEMA VTD Consolidation TRIAL In Autografted MULTIPLE Myeloma PATIENTS (VEL-03-096): IMPACT of Minimal RESIDUAL DISEASE Detection by REAL Time Quantitative PCR On LATE Recurrences and Overall SURVIVAL 72
Comparison of different DNA extraction methods from peripheral blood cells: advices from the Fondazione Italiana Linfomi - MRD Network. 72
Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome 69
Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia 67
null 64
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders 64
MINIMAL RESIDUAL DISEASE (MRD) DETECTION BY NEXT GENERATION SEQUENCING AND REAL TIME QUANTITATIVE–PCR: A METHODICAL COMPARISON IN ALL, MCL AND MM 63
Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients 61
Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans 58
COMPARISON OF DIFFERENT RQ-PCR DESIGN STRATEGIES FOR MINIMAL RESIDUAL DISEASE DETECTION IN LYMPHOPROLIFERATIVE DISORDERS: CORRELATION BETWEEN IMMUNOGLOBULIN GENE MUTATION LOAD AND RQ-PCR PERFORMANCE 51
HIGH RATES OF PROLONGED MOLECULAR REMISSIONS AFTER TANDEM AUTOLOGOUS-NONMYELOABLATIVE ALLOGRAFTING IN NEWLY DIAGNOSED MYELOMA 48
A COMPARATIVE ANALYSIS OF NEXT GENERATION SEQUENCING AND REAL TIME QUANTITATIVE–PCR FOR MINIMAL RESIDUAL DEECTION IN FOLLICULAR LYMPHOMA 47
SYNDECAN-1 PROMOTES THE ANGIOGENIC PHENOTYPE OF MULTIPLE MYELOMA ENDOTHELIAL CELLS 43
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma 38
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma. 17
Totale 2.609
Categoria #
all - tutte 5.931
article - articoli 0
book - libri 0
conference - conferenze 1.997
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.928


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019217 0 0 0 0 0 14 26 47 6 41 55 28
2019/2020414 9 8 20 65 30 68 64 24 33 34 40 19
2020/2021292 39 22 23 18 25 11 19 15 28 17 45 30
2021/2022350 9 6 2 19 7 13 66 23 9 27 103 66
2022/2023600 60 64 12 68 44 134 40 39 60 37 16 26
2023/2024186 30 72 21 12 20 31 0 0 0 0 0 0
Totale 2.609